**Core Concept:** Potassium channels are transmembrane proteins embedded in the cell membrane that regulate the flow of potassium ions across the membrane. Potassium channel openers are drugs that mimic the action of endogenous substances (e.g., bradykinin) to enhance potassium ion flow, leading to a hyperpolarizing effect on cells.

**Why the Correct Answer is Right:** Verapamil is a calcium channel blocker that inhibits voltage-dependent calcium channels, thus decreasing intracellular calcium concentration. This leads to a secondary increase in potassium efflux through voltage-dependent potassium channels, resulting in a hyperpolarizing effect on cardiac and smooth muscle cells. Verapamil is widely used in the treatment of hypertension and angina pectoris.

**Why Each Wrong Option is Incorrect:**

A. Nifedipine is a calcium channel blocker but acts on L-type calcium channels, not potassium channels. It has a different mechanism of action than verapamil or the correct answer.

B. Diltiazem is another calcium channel blocker that inhibits L-type calcium channels, similar to nifedipine. It does not target potassium channels like the correct answer.

C. Amiodarone is an antiarrhythmic drug that modulates multiple ion channels, including potassium channels. However, its primary mechanism of action is distinct from verapamil and the correct answer.

D. Diazoxide is a hypoglycemic drug that acts on pancreatic beta cells to stimulate insulin release and improve glucose homeostasis. It does not involve potassium channels like the correct answer.

**Clinical Pearl:** Verapamil is an example of a calcium channel blocker with a unique mechanism that effectively treats cardiovascular disorders by targeting both calcium entry and potassium efflux.

**Correct Answer:** Verapamil (Correct Answer: Verapamil) is a calcium channel blocker that increases potassium efflux through voltage-dependent potassium channels, leading to hyperpolarization of cardiac and smooth muscle cells. This property is not shared by the other options.